FDA Drug recall D-0654-2022
Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY
- FDA Drug
- Class II
- terminated
- Published 2022-03-23
On 2022-03-23 the FDA classified a Class II recall of Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY by Golden State Medical Supply, citing CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0654-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-03-02 |
| Published | 2022-03-23 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Golden State Medical Supply |
| Distribution | n/a |
Product
Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.
Reason
CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
Identifiers
| code_info | Lot #: GS027852, Expiry: 06/2022. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0654-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.